GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

More than 36 million Americans have type 2 diabetes, a condition primarily attributed to the body's cells not responding to ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

As type 3 diabetes isn't recognised as an official diagnosis, there isn't a single treatment for it. Instead, individuals with prediabetes, type 2 diabetes, and Alzheimer's disease have different ...

As type 3 diabetes isn't recognised as an official diagnosis, there isn't a single treatment for it. Instead, individuals with prediabetes, type 2 diabetes, and Alzheimer's disease have different ...